Jieling Zheng
- Cancer Research top 10%
- Cancer-related molecular mechanisms research 5
- Protease and Inhibitor Mechanisms 2
-
- Peptidase Inhibition and Analysis 5
-
- RNA modifications and cancer 5
- Circular RNAs in diseases 2
- RNA Research and Splicing 2
-
- Cardiac Structural Anomalies and Repair 4
-
- Radiopharmaceutical Chemistry and Applications 2
- Cited by
- Cancer ResearchOncologyGenetics
- Partner nations
- ChinaUnited StatesCzechia
In The Last Decade
Jieling Zheng
20 papers receiving 328 citations
Peers
Comparison fields: 5 of 61
- Cancer Research 166
- Oncology 110
- Genetics 25
- Molecular Biology 160
- Pulmonary and Respiratory Medicine 62
Countries citing papers authored by Jieling Zheng
This map shows the geographic impact of Jieling Zheng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jieling Zheng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jieling Zheng more than expected).
Fields of papers citing papers by Jieling Zheng
This network shows the impact of papers produced by Jieling Zheng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jieling Zheng. The network helps show where Jieling Zheng may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Jieling Zheng, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 3 | |
| 2 | 2024 | 3 | |
| 3 | 2024 | 4 | |
| 4 | 2023 | 10 | |
| 5 | 2023 | 0 | |
| 6 | 2023 | 3 | |
| 7 | 2022 | 10 | |
| 8 | 2021 | 8 | |
| 9 | 2021 | 43 | |
| 10 | 2020 | 11 | |
| 11 | 2020 | 3 | |
| 12 | 2020 | 45 | |
| 13 | 2020 | 5 | |
| 14 | 2019 | 16 | |
| 15 | 2019 | 68 | |
| 16 | 2018 | 40 | |
| 17 | 2018 | 1 | |
| 18 | 2017 | 5 | |
| 19 | 2017 | 2 | |
| 20 | 2017 | 29 |
About Jieling Zheng
Jieling Zheng is a scholar working on Cancer Research, Oncology and Immunology and Allergy, having authored 21 papers that have together received 331 indexed citations. Recurring topics across this work include RNA modifications and cancer (5 papers), Peptidase Inhibition and Analysis (5 papers), Cancer-related molecular mechanisms research (5 papers), Cardiac Structural Anomalies and Repair (4 papers), Radiopharmaceutical Chemistry and Applications (2 papers), Circular RNAs in diseases (2 papers), Protease and Inhibitor Mechanisms (2 papers) and RNA Research and Splicing (2 papers). The work is most often cited by research in Cancer Research (166 citations), Oncology (110 citations) and Genetics (25 citations). Jieling Zheng has collaborated with scholars based in China, United States and Czechia. Frequent co-authors include Yawei Yuan, Baiyao Wang, Jie Lin, Yunhong Tian, Anan Xu, Weibing Miao, Mengzhong Liu, Guozhu Xie, Aimin Ji and Shaobo Yao.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.